Concepedia

Lata Maganti

LM

Statistics

Publications

5

Citations

176

H-Index

5

Active since

2006

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

University of Missouri–Kansas City

Children's Mercy Hospital

Lata Maganti is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in drug safety, pediatrics, and pharmacokinetics.

Top concepts

Publications per year

2006–2018

5

Publications

5

Potent and Selective Agonism of the Melanocortin Receptor 4 With MK-0493 Does Not Induce Weight Loss in Obese Human Subjects: Energy Intake Predicts Lack of Weight Loss Efficacy

Rajesh Krishna, Barry Gumbiner, C. Melinda Stevens et al. · Clinical Pharmacology & Therapeutics · 2009 · 83 citations

Pharmacokinetics and Safety of Montelukast Oral Granules in Children 1 to 3 Months of Age With Bronchiolitis

Gregory L. Kearns, Susan Lu, Lata Maganti et al. · The Journal of Clinical Pharmacology · 2008 · 28 citations

, , +12

Pharmacokinetics and Safety of Montelukast in Children Aged 3 to 6 Months

Barbara Knorr, Lata Maganti, Rohini Ramakrishnan et al. · The Journal of Clinical Pharmacology · 2006 · 28 citations

Bioavailability of Alendronate and Vitamin D<sub>3</sub>in an Alendronate/Vitamin D<sub>3</sub>Combination Tablet

Andrew Denker, Nicole H. Lazarus, Arturo G. Porras et al. · The Journal of Clinical Pharmacology · 2010 · 21 citations

A randomized clinical trial to evaluate the single-dose pharmacokinetics, pharmacodynamics, and safety of sitagliptin in pediatric patients with type 2 diabetes

Iain P. Fraser, Naomi D Neufeld, Larry A. Fox et al. · Pediatric Diabetes · 2018 · 16 citations · Full text

1–5 of 5